Secondary |
Product Used For Unknown Indication |
47.9% |
Blood Cholesterol Increased |
15.5% |
Drug Use For Unknown Indication |
14.1% |
Dyspepsia |
4.2% |
Pain |
4.2% |
Vitamin Supplementation |
4.2% |
Alcoholism |
2.8% |
Blood Cholesterol |
1.4% |
Diabetes Mellitus Non-insulin-dependent |
1.4% |
Hypertension |
1.4% |
Implantable Defibrillator Insertion |
1.4% |
Joint Swelling |
1.4% |
|
Foetal Alcohol Syndrome |
23.5% |
Urticaria |
17.6% |
Circulatory Collapse |
5.9% |
Maternal Drugs Affecting Foetus |
5.9% |
Osteopenia |
5.9% |
Polycythaemia |
5.9% |
Rash |
5.9% |
Renal Disorder |
5.9% |
Sopor |
5.9% |
Visual Acuity Reduced Transiently |
5.9% |
Vomiting |
5.9% |
Wrong Drug Administered |
5.9% |
|
Concomitant |
Product Used For Unknown Indication |
45.7% |
Drug Use For Unknown Indication |
10.4% |
Hypertension |
4.2% |
Crohn's Disease |
4.2% |
Pain |
4.0% |
Rheumatoid Arthritis |
3.8% |
Vitamin Supplementation |
3.5% |
Depression |
3.3% |
Hepatitis C |
2.4% |
Multiple Sclerosis |
2.0% |
Hiv Infection |
1.9% |
Blood Cholesterol Increased |
1.9% |
Osteoporosis |
1.8% |
Prophylaxis |
1.8% |
Diabetes Mellitus |
1.6% |
Foetal Exposure During Pregnancy |
1.5% |
Anxiety |
1.5% |
Breast Cancer |
1.5% |
Psoriasis |
1.5% |
Supplementation Therapy |
1.5% |
|
Vomiting |
12.6% |
Weight Increased |
9.7% |
Weight Decreased |
9.0% |
Nausea |
5.6% |
Drug Ineffective |
5.4% |
Pain |
5.4% |
Pain In Extremity |
4.7% |
Urinary Tract Infection |
4.5% |
Pruritus |
4.3% |
Death |
4.0% |
Injection Site Pain |
4.0% |
Paraesthesia |
4.0% |
Pyrexia |
4.0% |
Rash |
4.0% |
Fatigue |
3.4% |
Hepatic Enzyme Increased |
3.4% |
Tremor |
3.1% |
Vision Blurred |
3.1% |
Flushing |
2.9% |
Pneumonia |
2.9% |
|
Interacting |
Neuropathy Peripheral |
33.3% |
Prostatic Disorder |
25.0% |
Gastrooesophageal Reflux Disease |
20.8% |
Hypercholesterolaemia |
12.5% |
Convulsion |
8.3% |
|
Neuropathy Peripheral |
40.0% |
Arthralgia |
20.0% |
Nausea |
20.0% |
Vitamin B12 Deficiency |
20.0% |
|